£2.48m
−30%vs Jun 2024Active12062536Private limited companyReading
272BIO LIMITED
Significant control: Charles Edward Owen (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for 272bio Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does 272bio Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
272BIO LIMITED is an active private limited company (company number 12062536) incorporated on 21 June 2019, registered in Reading. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of £2.48m and cash of £814k, with 21 employees on average. Net assets fell 30% on the prior period (£3.56m).
Peer position · net assets
By net assets it sits in the top quarter of 50 comparable companies in Reading (median £11k, upper quartile £207k).
02
Ownership and control
- Dr Charles Edward Owen
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 21 June 20197 yrs ago
- Next accounts due
- 30 March 2027in 157 days
- Confirmation statement due
- 5 July 2027in 254 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
05
Financials
£814k
−65%vs Jun 2024Not reported
21
+50%vs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £2.48m | £814k | £1.39m | — | — | — | 21 |
| 30 June 2024 | £3.56m | £2.30m | £1.23m | — | — | — | 14 |
Cash per employee£39kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,482,406 at 30 June 2025
- Net assets down 25% or more on the prior period-30.4% vs prior period
- Cash at bank of £50,000 or moreCash £813,648
- Incorporated five or more years agoIncorporated 21 June 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 254 days
- Next accounts duein 157 days
- Accounts period endNet assets £2.48m · small accounts
- Accounts period endNet assets £3.56m · small accounts
- Incorporated
08
Similar companies in Reading
- DIABETES RELAX LIMITEDMaidenhead · inc. Feb 2019
- HINZE TECH OPERATIONS LTDHook · inc. Nov 2019
- ELIXA MEDISCIENCE LTDAscot · inc. Nov 2019
- PRECISION ME LTDDatchet · inc. Dec 2018
- FISCHER CONSULTING LIMITEDMarlow · inc. Dec 2019
- DBP R&D CONSULTING LTDSlough · inc. Dec 2018
All companies incorporated on 21 June 2019 · in Jun 2019.
09
Reminders for 272BIO LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.